Cantor Fitzgerald Downgrades Salix Pharmaceuticals (SLXP) to Hold
Tweet
Share
E-mailGet Alerts SLXP Hot Sheet
Price: $172.81 --0%
Rating Summary:
7 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 13 | New: 23
Rating Summary:
7 Buy, 14 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 13 | New: 23
Join SI Premium – FREE
Cantor Fitzgerald downgraded Salix Pharmaceuticals (NASDAQ: SLXP) from Buy to Hold.
For an analyst ratings summary and ratings history on Salix Pharmaceuticals click here. For more ratings news on Salix Pharmaceuticals click here.
Shares of Salix Pharmaceuticals closed at $155.76 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Downgrades L'Oreal SA (OR:FP) (LRLCY) to Sell
- Wolfe Research Downgrades Home Depot (HD) to Peerperform
- Daiwa Securities Downgrades JD.com, Inc (JD) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
Cantor FitzgeraldSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
